Oral reduced B-nicotinamide adenine dinucleotide (NADH) affects blood pressure, lipid peroxidation, and lipid profile in hypertensive rats (SHR).

Geriatric nephrology and urology

Volumn 8, Issue 2, 1998, Pages 95-100

  Bushehri, N ^a   Jarrell, S T ^a   Lieberman, S ^a   Mirdamadi Zonozi, N ^a   Birkmayer, G ^a   Preuss, H G ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; BODY WEIGHT; DRUG EFFECT; HYPERTENSION; LIPID METABOLISM; LIPID PEROXIDATION; MALE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ADMINISTRATION, ORAL; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, LDL; HYPERTENSION; LIPID METABOLISM; LIPID PEROXIDATION; MALE; NAD; RATS; RATS, INBRED SHR;

EID: 0032247735     PISSN: 09248455     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1008242900153     Document Type: Article

References (0)